tiprankstipranks
Perfect Medical Health Management Limited (HK:1830)
HKEX:1830
Hong Kong Market
1830
Perfect Medical Health Management Limited
RESEARCH TOOLSreports

Perfect Medical Health Management Limited (1830) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

1830 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Perfect
Medical Health Management Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1830 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1830 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1830 Financial Forecast

1830 Earnings Forecast

The previous quarter’s earnings for 1830 were HK$0.12.
The previous quarter’s earnings for 1830 were HK$0.12.

1830 Sales Forecast

The previous quarter’s earnings for 1830 were HK$675.19M.
The previous quarter’s earnings for 1830 were HK$675.19M.

Detailed List of Analyst Forecasts​

Analyst Performance
Any
Any
Analyst Rating
Any
Any
Upside / Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CGS-CIMB
HK$8
Buy
HK$8.00
(206.51% Upside)
Initiated
07/31/23
We project PM’s net profit to rise at a 36% CAGR in FY3/24F-26F, primarily due to 1) faster store expansion in HK and China, 2) increased store traffic, and 3) higher spending per customer. We believe PM has a competitive edge over its HK rivals due to its 1) operational model with lower expenses for practitioners achieving higher profitability, 2) extensive network in 3) premium and safe services offered by an experienced management team and professional services team (therapists). HK/China store count to double by FY3/26F; target premium market PM’s main earnings contributors were HK which formed 75% of FY3/23 revenue and FY3/23 revenue. PM intends to accelerate its store openings in FY3/24-26F in a bid to capitalise on the fast-growing aesthetic medical market in HK/China.

Best Analysts Covering Perfect Medical Health Management Limited

Which Analyst Should I Follow If I Want to Buy HK:1830 and Sell After:
1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.50%
initiated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -6.50% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-12.00%
initiated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -12.00% per trade.
1 Year
Ray KWOK CFACGS-CIMB
Success Rate
0/1 ratings generated profit
0%
Average Return
-34.80%
initiated a buy rating 12 months ago
Copying Ray KWOK CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -34.80% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-34.80%
initiated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -34.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1830 Analyst Recommendation Trends

Rating
Jul 23
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, 1830 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1830 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector
Find stocks in the Consumer Cyclical sector that are highly recommended by Top Performing Analysts.

1830 Stock Forecast FAQ

What is HK:1830’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1830’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1830, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Perfect Medical Health Management Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Perfect Medical Health Management Limited’s share price target?
      Currently, no data Available
      What do analysts say about Perfect Medical Health Management Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Perfect Medical Health Management Limited?
      To buy shares of HK:1830, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis